BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lan T, Chen L, Wei X. Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy. Cells 2021;10:E100. [PMID: 33429846 DOI: 10.3390/cells10010100] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 21.5] [Reference Citation Analysis]
Number Citing Articles
1 Frankel LR, Ardeljan A, Obaed NG, Takabe K, Rashid O. Clostridium difficile Infection Is Associated With Decreased Prostate Cancer Risk: A Retrospective Cohort Study. Cureus 2023. [DOI: 10.7759/cureus.34398] [Reference Citation Analysis]
2 Tahmasebi S, Alimohammadi M, Khorasani S, Rezaei N. Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_25-1] [Reference Citation Analysis]
3 Jain N, Shahrukh S, Famta P, Shah S, Vambhurkar G, Khatri DK, Singh SB, Srivastava S. Immune cell-camouflaged surface-engineered nanotherapeutics for cancer management. Acta Biomater 2023;155:57-79. [PMID: 36347447 DOI: 10.1016/j.actbio.2022.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Braumüller H, Mauerer B, Andris J, Berlin C, Wieder T, Kesselring R. The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies. Cells 2022;12. [PMID: 36611932 DOI: 10.3390/cells12010138] [Reference Citation Analysis]
5 Konnova A, De Winter FHR, Gupta A, Verbruggen L, Hotterbeekx A, Berkell M, Teuwen LA, Vanhoutte G, Peeters B, Raats S, der Massen IV, De Keersmaecker S, Debie Y, Huizing M, Pannus P, Neven KY, Ariën KK, Martens GA, Bulcke MVD, Roelant E, Desombere I, Anguille S, Berneman Z, Goossens ME, Goossens H, Malhotra-Kumar S, Tacconelli E, Vandamme T, Peeters M, van Dam P, Kumar-Singh S. Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors. Front Immunol 2022;13:1062136. [PMID: 36618384 DOI: 10.3389/fimmu.2022.1062136] [Reference Citation Analysis]
6 Ouyang K, Zheng DX, Agak GW. T-Cell Mediated Immunity in Merkel Cell Carcinoma. Cancers (Basel) 2022;14. [PMID: 36551547 DOI: 10.3390/cancers14246058] [Reference Citation Analysis]
7 Polityńska B, Pokorska O, Wojtukiewicz AM, Sawicka M, Myśliwiec M, Honn KV, Tucker SC, Wojtukiewicz MZ. Is depression the missing link between inflammatory mediators and cancer? Pharmacol Ther 2022;240:108293. [PMID: 36216210 DOI: 10.1016/j.pharmthera.2022.108293] [Reference Citation Analysis]
8 Zhao R, Xie C, Gong Y, Wei S, Yuan M, Gan J, Chen W. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/5468858] [Reference Citation Analysis]
9 Franzese O, Graziani G. Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints. Cancers (Basel) 2022;14. [PMID: 36428727 DOI: 10.3390/cancers14225633] [Reference Citation Analysis]
10 Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1051998] [Reference Citation Analysis]
11 Zaman R, Islam RA, Chowdhury EH. Evolving therapeutic proteins to precisely kill cancer cells. Journal of Controlled Release 2022;351:779-804. [DOI: 10.1016/j.jconrel.2022.09.066] [Reference Citation Analysis]
12 Huang A, Groer C, Lu R, Forrest ML, Griffin JD, Berkland CJ. Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1. Mol Pharmaceutics 2022. [DOI: 10.1021/acs.molpharmaceut.2c00730] [Reference Citation Analysis]
13 Budek M, Nuszkiewicz J, Piórkowska A, Czuczejko J, Szewczyk-Golec K. Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms. Biomedicines 2022;10:2660. [PMID: 36289922 DOI: 10.3390/biomedicines10102660] [Reference Citation Analysis]
14 Pangath M, Unnikrishnan L, Throwba PH, Vasudevan K, Jayaraman S, Li M, Iyaswamy A, Palaniyandi K, Gnanasampanthapandian D. The Epigenetic Correlation among Ovarian Cancer, Endometriosis and PCOS: A Review. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103852] [Reference Citation Analysis]
15 Konnova A, De Winter FH, Gupta A, Verbruggen L, Hotterbeekx A, Berkell M, Teuwen L, Vanhoutte G, Peeters B, Raats S, Van der Massen I, De Keersmaecker S, Debie Y, Huizing M, Pannus P, Neven KY, Ariën KK, Martens GA, Van Den Bulcke M, Roelant E, Desombere I, Anguille S, Berneman Z, Goossens ME, Goossens H, Malhotra-kumar S, Taconelli E, Vandamme T, Peeters M, van Dam P, Kumar-singh S. Predictive model for BNT162b2 vaccine response in cancer patients based on cytokines and growth factors.. [DOI: 10.1101/2022.09.25.22280267] [Reference Citation Analysis]
16 Bhattacharya S. Metabolic Reprogramming and Cancer: 2022. Qeios 2022. [DOI: 10.32388/ck9vjb.3] [Reference Citation Analysis]
17 Lee H, Lee H, Chang J. Inflammatory Cytokine: An Attractive Target for Cancer Treatment. Biomedicines 2022;10:2116. [DOI: 10.3390/biomedicines10092116] [Reference Citation Analysis]
18 Bhattacharya S. Metabolic Reprogramming and Cancer: 2022. Qeios 2022. [DOI: 10.32388/ck9vjb.2] [Reference Citation Analysis]
19 Santolla MF, Talia M, Cirillo F, Scordamaglia D, De Rosis S, Spinelli A, Miglietta AM, Nardo B, Filippelli G, De Francesco EM, Belfiore A, Lappano R, Maggiolini M. The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells. Cells 2022;11:2402. [DOI: 10.3390/cells11152402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ura B, Capaci V, Aloisio M, Di Lorenzo G, Romano F, Ricci G, Monasta L. A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer. Biomedicines 2022;10:1857. [DOI: 10.3390/biomedicines10081857] [Reference Citation Analysis]
21 bhattacharya S. Metabolic Reprogramming and Cancer: 2022.. [DOI: 10.32388/ck9vjb] [Reference Citation Analysis]
22 Chen Z, Hao X, Wang H, Zhong X, Chen X, Zhao Y, Zhang Y, Du G, Sun X. Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses. J Control Release 2022;349:699-711. [PMID: 35907590 DOI: 10.1016/j.jconrel.2022.07.032] [Reference Citation Analysis]
23 Ni Y, Low JT, Silke J, O'Reilly LA. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers. Front Immunol 2022;13:835997. [PMID: 35844493 DOI: 10.3389/fimmu.2022.835997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhukova OV, Arkhipova EV, Kovaleva TF, Zykova DA, Dubovskaya NA. Effect of Poly(methacrylic acid) on the Cytokine Level in an In Vivo Tumor Model. Molecules 2022;27:4572. [DOI: 10.3390/molecules27144572] [Reference Citation Analysis]
25 Xu C, Chang J, Li Y, Wang K, Pan W, Wang H, Li N, Tang B. An active tumor-targeting organic photochemotherapy agent with naproxen for enhanced cancer therapy. Chem Commun (Camb) 2022. [PMID: 35833234 DOI: 10.1039/d2cc01729f] [Reference Citation Analysis]
26 Gunes-bayir A, Guler EM, Bilgin MG, Ergun IS, Kocyigit A, Dadak A. Anti-Inflammatory and Antioxidant Effects of Carvacrol on N-Methyl-N′-Nitro-N-Nitrosoguanidine (MNNG) Induced Gastric Carcinogenesis in Wistar Rats. Nutrients 2022;14:2848. [DOI: 10.3390/nu14142848] [Reference Citation Analysis]
27 Shinoda S, Nakamura N, Roach B, Bernlohr DA, Ikramuddin S, Yamamoto M. Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. Biomedicines 2022;10:1284. [DOI: 10.3390/biomedicines10061284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Benot-Dominguez R, Cimini A, Barone D, Giordano A, Pentimalli F. The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers? Cancers (Basel) 2022;14:2709. [PMID: 35681689 DOI: 10.3390/cancers14112709] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Guo Y, Ma B, Li X, Hui H, Zhou Y, Li N, Xie X. n-3 PUFA can reduce IL-6 and TNF levels in patients with cancer. Br J Nutr 2022. [DOI: 10.1017/s0007114522000575] [Reference Citation Analysis]
30 Afshari AR, Sanati M, Mollazadeh H, Kesharwani P, Johnston TP, Sahebkar A. Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. Semin Cancer Biol 2022:S1044-579X(22)00018-9. [PMID: 35115226 DOI: 10.1016/j.semcancer.2022.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
31 Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Aoki I, Obata T, Higashi T, Bakalova R. Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State. Cancers 2022;14:485. [DOI: 10.3390/cancers14030485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Zick Y. Galectin-8, cytokines, and the storm. Biochem Soc Trans 2022:BST20200677. [PMID: 35015084 DOI: 10.1042/BST20200677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Katongole P, Sande OJ, Nabweyambo S, Joloba M, Kajumbula H, Kalungi S, Reynolds SJ, Ssebambulidde K, Atuheirwe M, Orem J, Niyonzima N. IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute. Future Oncol 2021. [PMID: 34881637 DOI: 10.2217/fon-2021-0683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Savanur MA, Weinstein-Marom H, Gross G. Implementing Logic Gates for Safer Immunotherapy of Cancer. Front Immunol 2021;12:780399. [PMID: 34804073 DOI: 10.3389/fimmu.2021.780399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 De Winter FHR, Hotterbeekx A, Huizing MT, Konnova A, Fransen E, Jongers B, Jairam RK, Van Averbeke V, Moons P, Roelant E, Le Blon D, Vanden Berghe W, Janssens A, Lybaert W, Croes L, Vulsteke C, Malhotra-Kumar S, Goossens H, Berneman Z, Peeters M, van Dam PA, Kumar-Singh S. Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients. Cancers (Basel) 2021;13:5718. [PMID: 34830872 DOI: 10.3390/cancers13225718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Grace VMB, Wilson DD, Anushya R, Siddikuzzaman. Regulation of inflammation and COX-2 gene expression in benzo (a) pyrene induced lung carcinogenesis in mice by all trans retinoic acid (ATRA). Life Sci 2021;285:119967. [PMID: 34543639 DOI: 10.1016/j.lfs.2021.119967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 De Winter FH, Hotterbeekx A, Huizing M, Konnova A, Fransen E, Jongers B, Jairam RK, Van averbeke V, Moons P, Roelant E, Le Blon D, Berghe WV, Janssens A, Lybaert W, Croes L, Vulsteke C, Malhotra-kumar S, Goossens H, Berneman Z, Peeters M, van Dam P, Kumar-singh S. Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients.. [DOI: 10.1101/2021.10.29.21265511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Basheer AS, Abas F, Othman I, Naidu R. Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications. Cancers (Basel) 2021;13:4226. [PMID: 34439380 DOI: 10.3390/cancers13164226] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]